Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Background: Endogenous plasma cortisol levels have a well-defined circadian rhythm. The aim of this project is to develop a once daily oral dual-release formulation for cortisol replacement therapy that mimics the diurnal variation in the plasma cortisol profile. Objective: To determine single-dose plasma pharmacokinetics and dose-proportionality of oral 5 and 20 mg dual-release hydrocortisone tablets in healthy volunteers. In addition, the effect of food intake was investigated for the 20 mg dose. Design: A randomised, controlled, two-way cross-over, double-blind, phase I study of oral hydrocortisone (modified (dual) release; 5 and 20 mg) with an open food-interaction arm. Methods: The single dose pharmacokinetic studies were performed with betamethasone suppression. The two first study days were blinded and randomised between morning administration of 5 and 20 mg tablet in a fasting state. The third day was open with a 20 mg tablet taken 30 min after a high-calorie, high-fat meal. The plasma samples were assayed using both a validated LC–MS/MS and an immunoassay. The plasma pharmacokinetic variables were calculated using non-compartmental data analysis. Results: The time to reach a clinically significant plasma concentration of cortisol (>200 nmol/l) was within 20 min and a mean peak of 431 (s.d. 126) nmol/l was obtained within 50 min after administration of the 20 mg tablet. Plasma cortisol levels remained above 200 nmol/l for around 6 h thereafter and all plasma concentrations 18–24 h after intake were below 50 nmol/l. In the fed state the time to reach 200 nmol/l was delayed by 28 and 9 min based on LC–MS/MS and immunoassay, respectively. The 5 and 20 mg tablets produced an increase in plasma exposure of cortisol that was not fully dose proportional. Conclusion: The dual release hydrocortisone tablet with once-daily administration produced a diurnal plasma cortisol profile mimicking the physiological serum cortisol profile.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the physiological rise in cortisol early morning is not well mimicked (123-125).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [125]
In the citing paper
“Modified release HC is commercially approved in Europe as a once-a-day tablet with combined immediate and extended release characteristics capable of achieving a more physiological plasma cortisol profile.”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [125]
In the citing paper
“This therapy induces a physiological cortisol profile in the early part of the day and received EMA approval (2011) for the treatment of adrenal insufficiency104,105.”
From Management challenges and therapeutic advances in congenital adrenal hyperplasia (2022) · cites this paper as [104]
Citations
Cites
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
Bioanalytical Method Validation—A Revisit with a Decade of Progress
Shah, V. P., Midha, K. K., Findlay, J. W. A., Hill, H. M., Hulse, J. D., McGilveray, I. J., McKay, G., Miller, K. J., Patnaik, R. N., Powell, M. L., et al. (2000) · Pharmaceutical Research · doi:10.1023/a:1007669411738 · Cited by 1,572
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402
Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects
WEITZMAN, E. D., FUKUSHIMA, D., NOGEIRE, C., ROFFWARG, H., GALLAGHER, T. F., & HELLMAN, L. (1971) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-33-1-14 · Cited by 1,258
Analytical Methods Validation: Bioavailability, Bioequivalence, and Pharmacokinetic Studies
Shah, V. P., Midha, K. K., Dighe, S., McGilveray, I. J., Skelly, J. P., Yacobi, A., Layloff, T., Viswanathan, C. T., Edgar Cook, C., Mcdowall, R. D., et al. (1992) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600810324 · Cited by 1,121
Association between premature mortality and hypopituitarism
Tomlinson, J., Holden, N., Hills, R., Wheatley, K., Clayton, R., Bates, A., Sheppard, M., & Stewart, P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04006-x · Cited by 1,006
Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.
Czock, D., Keller, F., Rasche, F. M., & H??ussler, U. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544010-00003 · Cited by 886
Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone.
Ueda, K., Okamura, N., Hirai, M., Tanigawara, Y., Saeki, T., Kioka, N., Komano, T., & Hori, R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35757-0 · Cited by 673
(1991) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03189968 · Cited by 614
Premature Mortality in Patients with Addison’s Disease: A Population-Based Study
Bergthorsdottir, R., Leonsson-Zachrisson, M., Odén, A., & Johannsson, G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0076 · Cited by 490 · cited 1×
“120 G Johannsson and others EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009) 161”
BackgroundSelf-citationDaily cortisol production rate in man determined by stable isotope dilution/mass spectrometry
ESTEBAN, N. V., LOUGHLIN, T., YERGEY, A. L., ZAWADZKI, J. K., BOOTH, J. D., WINTERER, J. C., & LORIAUX, D. L. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-1-39 · Cited by 481
Minireview: Glucocorticoids—Food Intake, Abdominal Obesity, and Wealthy Nations in 2004
Dallman, M. F., la Fleur, S. E., Pecoraro, N. C., Gomez, F., Houshyar, H., & Akana, S. F. (2004) · Endocrinology · doi:10.1210/en.2004-0037 · Cited by 415
Modified-release hydrocortisone to provide circadian cortisol profiles
Debono, M., Ghobadi, C., Rostami-Hodjegan, A., Huatan, H., Campbell, M. J., Newell-Price, J., Darzy, K., Merke, D. P., Arlt, W., & Ross, R. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2380 · Cited by 322
Filipsson, H., Monson, J. P., Koltowska-Häggström, M., Mattsson, A., & Johannsson, G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0524 · Cited by 321
Self-citationIntestinal permeability and its relevance for absorption and elimination
Lennernäs, H. (2007) · Xenobiotica · doi:10.1080/00498250701704819 · Cited by 304
Hahner, S., Loeffler, M., Fassnacht, M., Weismann, D., Koschker, A.-C., Quinkler, M., Decker, O., Arlt, W., & Allolio, B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0685 · Cited by 282
Validation of Bioanalytical Methods
Karnes, H. T., Shiu, G., & Shah, V. P. (1991) · Pharmaceutical Research · doi:10.1023/a:1015882607690 · Cited by 260
Subjective health status in Norwegian patients with Addison’s disease.
Løvås, K., Loge, J. H., & Husebye, E. S. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01466.x · Cited by 256
Mah, P. M., Jenkins, R. C., Rostami‐Hodjegan, A., Newell‐Price, J., Doane, A., Ibbotson, V., Tucker, G. T., & Ross, R. J. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02106.x · Cited by 243
Bensing, S., Brandt, L., Tabaroj, F., Sjöberg, O., Nilsson, B., Ekbom, A., Blomqvist, P., & Kämpe, O. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03340.x · Cited by 242
A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome
Newell‐Price, J., Trainer, P., Perry, L., Wass, J., Grossman, A., & Besser, M. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02918.x · Cited by 229
Eight-six Cases of Adison's Disease
Dunlop, D. (1963) · BMJ · doi:10.1136/bmj.2.5362.887 · Cited by 217
Lennernäs, H., & Abrahamsson, B. (2005) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357055263 · Cited by 215
Glucocorticoid replacement therapy: are patients over treated and does it matter?
Peacey, S. R., Guo, C., Robinson, A. M., Price, A., Giles, M. A., Eastell, R., & Weetman, A. P. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.780907.x · Cited by 205
Cortisol production rate in childhood and adolescence
Linder, B. L., Esteban, N. V., Yergey, A. L., Winterer, J. C., Loriaux, D. L., & Cassorla, F. (1990) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80128-3 · Cited by 202
EPIDEMIOLOGICAL AND CLINICAL PICTURE OF ADDISON'S DISEASE
Stuart Mason, A., Meade, T. W., Lee, J. A. H., & Morris, J. N. (1968) · The Lancet · doi:10.1016/s0140-6736(68)90948-3 · Cited by 195
Long-Term DHEA Replacement in Primary Adrenal Insufficiency: A Randomized, Controlled Trial
Gurnell, E. M., Hunt, P. J., Curran, S. E., Conway, C. L., Pullenayegum, E. M., Huppert, F. A., Compston, J. E., Herbert, J., & Chatterjee, V. K. K. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1134 · Cited by 189
PATTERNS OF ACTH AND CORTISOL PULSATILITY OVER TWENTY‐FOUR HOURS IN NORMAL MALES AND FEMALES
HORROCKS, P. M., JONES, A. F., RATCLIFFE, W. A., HOLDER, G., WHITE, A., HOLDER, R., RATCLIFFE, J. G., & LONDON, D. R. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb03758.x · Cited by 177
Pharmacokinetics and Oral Bioavailability of Hydrocortisone
Derendorf, H., Möllmann, H., Barth, J., Möllmann, C., Tunn, S., & Krieg, M. (1991) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1991.tb01906.x · Cited by 168
Continuous subcutaneous hydrocortisone infusion in Addison’s disease
Løvås, K., & Husebye, E. S. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0052 · Cited by 155
Structural Determinants of P-Glycoprotein-Mediated Transport of Glucocorticoids
Yates, C. R., Chang, C. K., Kearbey, J. D., Yasuda, K., Schuetz, E. G., Miller, D. D., Dalton, J. T., & Swaan, P. W. (2003) · Pharmaceutical Research · doi:10.1023/b:pham.0000003377.39548.f6 · Cited by 124
Bottomed out: metabolic significance of the circadian trough in glucocorticoid concentrations
Dallman, M. F., Akana, S. F., Bhatnagar, S., Bell, M., & Strack, A. M. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801276 · Cited by 122
Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients
Mills, J. L., Schonberger, L. B., Wysowski, D. K., Brown, P., Durako, S. J., Cox, C., Kong, F., & Fradkin, J. E. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2003.12.036 · Cited by 118
Corticosteroid Replacement Therapy: Twice Or Thrice Daily?
Groves, R. W., Toms, G. C., Houghton, B. J., & Monson, J. P. (1988) · Journal of the Royal Society of Medicine · doi:10.1177/014107688808100906 · Cited by 107
Kraan, G. P. B., Dullaart, R. P. F., Pratt, J. J., Wolthers, B. G., Drayer, N. M., & de Bruin, R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.4.4694 · Cited by 100
Merza, Z., Rostami‐Hodjegan, A., Memmott, A., Doane, A., Ibbotson, V., Newell‐Price, J., Tucker, G. T., & Ross, R. J. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02544.x · Cited by 98
Translating Safety, Efficacy and Compliance into Economic Value for Controlled Release Dosage Forms
Cramer, M., & Saks, S. R. (1994) · PharmacoEconomics · doi:10.2165/00019053-199405060-00005 · Cited by 97
Comparison of the Mechanism of Dissolution of Hydrocortisone in Simple and Mixed Micelle Systems
Naylor, L. J. M., Bakatselou, V., & Dressman, J. (1993) · Pharmaceutical Research · doi:10.1023/a:1018961227717 · Cited by 94
Newell‐Price, J., Whiteman, M., Rostami‐Hodjegan, A., Darzy, K., Shalet, S., Tucker, G. T., & Ross, R. J. M. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03011.x · Cited by 85
Dissolution of Hydrocortisone in Human and Simulated Intestinal Fluids
Pedersen, B. L., BRØNDSTED, H. V., Lennernäs, H., Christensen, F. N., Müllertz, A., & Kristensen, H. G. (2000) · Pharmaceutical Research · doi:10.1023/a:1007517414200 · Cited by 83
Absorption of Steroid Hormones from the Human Small Intestine1
SCHEDL, H. P., White, D., & Miller, D. (1965) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-25-10-1309 · Cited by 61
Physicochemical Properties and Transport of Steroids Across Caco-2 Cells
Faassen, F., Kelder, J., Lenders, J., Onderwater, R. C. A., & Vromans, H. (2003) · Pharmaceutical Research · doi:10.1023/a:1022210801734 · Cited by 55
Thomson, A. H., Devers, M. C., Wallace, A. M., Grant, D., Campbell, K., Freel, M., & Connell, J. M. C. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02812.x · Cited by 49
Assessing the HPA axis in patients with pituitary disease: a UK survey
Reynolds, R. M., Stewart, P. M., Seckl, J. R., & Padfield, P. L. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02421.x · Cited by 48
Toothaker, R. D., & Welling, P. G. (1982) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01062332 · Cited by 47
Episodic ACTH and cortisol secretion in normal children
Wallace, W. H. B., Crowne, E. C., Shalet, S. M., Moore, C., Gibson, S., Utley, M. D., & White, A. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb00297.x · Cited by 44
Darzy, K. H., & Shalet, S. M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0830 · Cited by 38
Toothaker, R. D., Sundaresan, G. M., Hunt, J. P., Goehl, T. J., Rotenberg, K. S., Prasad, V. K., Craig, W. A., & Welling, P. G. (1982) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600710522 · Cited by 37
Effect of Dose Size on the Pharmacokinetics of Oral Hydrocortisone Suspension
Roger, D., Craig, W. A., & Welling, P. G. (1982) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600711029 · Cited by 37
Lennernäs, H., Skrtic, S., & Johannsson, G. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.6.749 · Cited by 25
Self-citationBlomgren, J., Ekman, B., Andersson, P., & Arnqvist, H. J. (2004) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510410004867 · Cited by 8
Cited by
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945
The Functional and Clinical Significance of the 24-Hour Rhythm of Circulating Glucocorticoids
Oster, H., Challet, E., Ott, V., Arvat, E., de Kloet, E. R., Dijk, D.-J., Lightman, S., Vgontzas, A., & Van Cauter, E. (2017) · Endocrine Reviews · doi:10.1210/er.2015-1080 · Cited by 548
“tisone, in addition to a very likely long-term improvement of medication adherence, enabled a closer approximation of the normal daytime cortisol secretory profile, as shown in Figure 14B (415, 416).”
Mortality in Patients with Pituitary Disease
Sherlock, M., Ayuk, J., Tomlinson, J. W., Toogood, A. A., Aragon-Alonso, A., Sheppard, M. C., Bates, A. S., & Stewart, P. M. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0033 · Cited by 392
Johannsson, G., Nilsson, A. G., Bergthorsdottir, R., Burman, P., Dahlqvist, P., Ekman, B., Engström, B. E., Olsson, T., Ragnarsson, O., Ryberg, M., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1926 · Cited by 329
“A novel once-daily (OD) dual-release hydrocortisone tablet, based on an immediate-release coating together with an extended-release core, was developed to obtain a more physiological circadian-based S-cortisol exposuretime profile (19).”
Self-citationReview: Replication of cortisol circadian rhythm: new advances in hydrocortisone replacement therapy
Chan, S., & Debono, M. (2010) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018810380214 · Cited by 243
“Serum cortisol persisted above 200 nmol/l for around 6 h thereafter whereas all serum concentrations 18 24 h after intake were below 50 nmol/l [Johannsson et al. 2009].”
Background
Metadata
- Authors
- Johannsson, G., Bergthorsdottir, R., Nilsson, A. G., Lennernas, H., Hedner, T., & Skrtic, S.
- Affiliations
- Sahlgrenska University Hospital (SE)
- University of Gothenburg (SE)
- Corresponding author
- Johannsson, Gudmundur
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-07
- Volume
- 161
- Issue
- 1
- Pages
- 119-130
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2120077291
- Semantic Scholar
- 9fbbc372f2c30c439128fc0a594197b3b9c66cc3
- Cited by
- 173
- References
- 52
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 9 · 2023: 7 · 2022: 8 · 2021: 12 · 2020: 9 · 2019: 10 · 2018: 13 · 2017: 14 · 2016: 14 · 2015: 6 · 2014: 18 · 2013: 14 · 2012: 7
- FWCI
- 6.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Lunds Universitet
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- cortisol, glucocorticoid replacement therapy, modified release tablets, once-daily dosing, diurnal cortisol rhythm, food effect, dose proportionality
- MeSH terms
- Administration, Oral, Adolescent, Adult, Aged, Anti-Inflammatory Agents, Circadian Rhythm, Eating, Female, Humans, Hydrocortisone, Male, Middle Aged, Tablets, Cross-Over Studies, Hormone Replacement Therapy, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.